Showing results (271-280 of 6,284) with videos related to
Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|January 3, 2013
Current therapeutic interventions in the glycation pathway: evidence from clinical studiesL Engelen, C D A Stehouwer, C G SchalkwijkDiabetes, Obesity & Metabolism|December 13, 2012
The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trialX L Tong, S T Wu, F M Lian, et al.Diabetes, Obesity & Metabolism|February 15, 2013
Reduced postprandial GLP-1 responses in women with gestational diabetes mellitusL Bonde, T Vilsbøll, T Nielsen, et al.Diabetes, Obesity & Metabolism|March 8, 2013
Dose-ranging study with the glucokinase activator AZD1656 in patients with type 2 diabetes mellitus on metforminJ P H Wilding, M Leonsson-Zachrisson, C Wessman, et al.Diabetes, Obesity & Metabolism|March 8, 2013
Preferences for medication attributes among patients with type 2 diabetes mellitus in the UKH L Gelhorn, S M Stringer, A Brooks, et al.Diabetes, Obesity & Metabolism|March 8, 2013
Efficacy, safety and dose-response relationship of teneligliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitusT Kadowaki, K KondoDiabetes, Obesity & Metabolism|February 24, 2012
Initial combination of linagliptin and metformin improves glycaemic control in type 2 diabetes: a randomized, double-blind, placebo-controlled studyThomas Haak, T Meinicke, R Jones, et al.Diabetes, Obesity & Metabolism|April 5, 2013
The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatmentA Flint, C Kapitza, M ZdravkovicDiabetes, Obesity & Metabolism|April 19, 2013
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trialsM Monami, S Genovese, E MannucciPageof 629